This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,640.80, is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a prescription pharmaceutical product.
The award is associated with a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The IDC has a performance period extending through December 31, 2025.
The contract does not have a set-aside designation, indicating it was an unrestricted, full and open competition award.
Generated 3/21/25, 10:00 AM